<DOC>
	<DOCNO>NCT01443247</DOCNO>
	<brief_summary>The purpose study evaluate role anti-d dengue fever .</brief_summary>
	<brief_title>Role Andi-d Dengue Fever : Pilot Study</brief_title>
	<detailed_description>This study conduct pgimer . Patients present fever thrombocytopenia emergency medical opd / medicine opd screen dengue serology positive patient evaluate enrolment study . We propose enroll 30 patient diagnosed dengue haemorrhagic fever . diagnosis dengue fever base upon clinical history , general physical examination lab test : thrombocytopenia ( platelet count ≤ 20,000 ) , positive dengue serology . STUDY DESIGN : It open label inteventional study . one group 15 patient ( intervention group ) receive platelet support along injection anti-d dose 50 µg/kg ( 250IU/kg ) intravenously group 15 ( control group ) receive platelet support . base line platelet count participant study group take level platelet 12 , 24 , 36 , 48hr post treatment initiation note . The patient follow till time discharge .</detailed_description>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Dengue</mesh_term>
	<criteria>inclusion criterion : fever thrombocytopenia with/without bleed manifestation dengue serology positive patient platelet count ≤ 20,000/mm3 Rh positive patient willing give write informed consent exclusion criterion : dengue serology positive platelet count &gt; 20,000/mm3 Rh negative patient pregnant female</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>